QUALITY IMPROVEMENT
Reminders in echocardiography reports increased use of β blockers in reduced left ventricular ejection fraction
In patients with reduced left ventricular ejection fraction (LVEF), do clinical reminders attached to echocardiography reports increase use of β blockers?
| The first 150 words of the full text of this article appear below. |
Heidenreich PA, Gholami P, Sahay A, et al. Clinical reminders attached to echocardiography reports of patients with reduced left ventricular ejection fraction increase use of b-blockers. A randomized trial. Circulation 2007;115:2829–34.
Clinical impact ratings GP/FP/Primary care 





IM/Ambulatory care 





Cardiology 





METHODS
randomised controlled trial.
concealed.*
{blinded (data collectors)}
.*
9 months after echocardiography.
3 Veterans Affairs (VA) echocardiography laboratories in the US.
1546 patients with LVEF <45%, assessed by attending echocardiographer. Exclusion criteria were aortic stenosis (mean valve gradient
20 mm Hg) or mitral stenosis (mean gradient
5 mm Hg).
the echocardiography report of the reminder group (n = 755) included a written reminder that β blockers (carvedilol, initial dose 3.125 mg twice daily, or metoprolol, initial dose 12.5 mg twice daily) improve survival in patients with reduced LVEF and recommended cardiology follow-up for patients with New York Heart Association class III or IV symptoms. Reminders were not placed
United Arab Emirates University, Al Ain, United Arab Emirates
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
